Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Inventory Average (2016 - 2025)

Historic Inventory Average for Integra Lifesciences Holdings (IART) over the last 16 years, with Q3 2025 value amounting to $477.1 million.

  • Integra Lifesciences Holdings' Inventory Average rose 1112.47% to $477.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $477.1 million, marking a year-over-year increase of 1112.47%. This contributed to the annual value of $409.3 million for FY2024, which is 1463.29% up from last year.
  • Integra Lifesciences Holdings' Inventory Average amounted to $477.1 million in Q3 2025, which was up 1112.47% from $455.3 million recorded in Q2 2025.
  • Integra Lifesciences Holdings' Inventory Average's 5-year high stood at $477.1 million during Q3 2025, with a 5-year trough of $315.6 million in Q3 2022.
  • In the last 5 years, Integra Lifesciences Holdings' Inventory Average had a median value of $352.8 million in 2023 and averaged $370.7 million.
  • In the last 5 years, Integra Lifesciences Holdings' Inventory Average crashed by 648.23% in 2021 and then surged by 1917.45% in 2024.
  • Quarter analysis of 5 years shows Integra Lifesciences Holdings' Inventory Average stood at $322.3 million in 2021, then decreased by 1.38% to $317.8 million in 2022, then grew by 18.91% to $377.9 million in 2023, then increased by 14.57% to $433.0 million in 2024, then rose by 10.19% to $477.1 million in 2025.
  • Its Inventory Average stands at $477.1 million for Q3 2025, versus $455.3 million for Q2 2025 and $437.3 million for Q1 2025.